search
Back to results

The Influence of Electronic (ECIG) Heater Resistance on ECIG Acute Effects

Primary Purpose

Nicotine Dependence

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
ECIG Session
Sponsored by
Virginia Commonwealth University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Nicotine Dependence

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Willing to provide informed consent, attend the lab and abstain from nicotine/tobacco as required, and use designated products according to study protocol
  • Experienced ECIG users (use ≥1 ml of ECIG solution daily, use ECIG solution with a nicotine concentration ≥3 mg/ml, and have used their ECIG for ≥3 months)
  • Urine cotinine test result ≥ 3

Exclusion Criteria:

  • History of organ-related diseases or current psychiatric condition
  • Regular use of prescription medication other than vitamins or birth control
  • Past month use of cocaine, opioids, benzodiazepines, or methamphetamine
  • Using marijuana greater than 10 days in the past 30 and/or alcohol greater than 25 days in the past 30 days
  • Pregnant or breastfeeding women
  • Weight less than 110 pounds
  • Daily use of >5 cigarettes or use of other tobacco products (i.e., hookah, cigars) >3 times a week

Sites / Locations

  • Virginia Commonwealth University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Experimental

Arm Label

ECIG Session: 0.5 Ohms, 3 mg

ECIG Session 0.5 Ohms, 8 mg

ECIG Session 1.5 Ohms, 3 mg

ECIG Session 1.5 Ohms, 8 mg

Arm Description

Heating coil resistance 0.5 Ohms Liquid nicotine concentration 3 mg

Heating coil resistance 0.5 Ohms Liquid nicotine concentration 8 mg

Heating coil resistance 1.5 Ohms Liquid nicotine concentration 3 mg

Heating coil resistance 1.5 Ohms Liquid nicotine concentration 8 mg

Outcomes

Primary Outcome Measures

Cmax: Plasma nicotine concentration (ng/ml)

Secondary Outcome Measures

Withdrawal suppression: Hughes-Hatsukami Withdrawal Scale
Contains 11 items. Administered on a computerized visual analogue scale that consists of a phrase centered on a horizontal line with "not at all" on the left and "extremely" on the right.. Responses range from 0-100.
Withdrawal suppression: Direct effects of nicotine scale
Contains 9-items. Administered on a computerized visual analogue scale that consists of a phrase centered on a horizontal line with "not at all" on the left and "extremely" on the right.. Responses range from 0-100.
Withdrawal suppression: Tiffany Drobes Questionnaire of Smoking Urges
Contains 10 items. Participants will be asked to rate each phrase on a 7-point scale ranging from 0 (Strongly disagree) to 7 (Strongly agree). The items from this scale will form two factors: Factor 1 (intention to smoke) and Factor 2 (anticipation of relief from abstinence symptoms).
Withdrawal suppression: Direct effects of ECIG use scale
Contains 14-items. Administered on a computerized visual analogue scale that consists of a phrase centered on a horizontal line with "not at all" on the left and "extremely" on the right. Responses range from 0-100.
Other subjective effects: General Labeled Magnitude Scale
Contains 4-items. This category-ratio scale contains seven semantic labels that increase in sensitivity including: "no sensation", "barely detectable", "weak", "moderate", "strong", "very strong", and "strongest imaginable sensation of any kind." Responses will be coded on a 0-100 scale.
Other subjective effects: Labeled Hedonic Scale
Contains 4-items. This category-ratio scale contains ten semantic labels, intended to assess participant liking or disliking of sensations experienced in the general labeled magnitude scale.. Semantic labels include: "most liked sensation imaginable", "like extremely", "like very much", "like moderately", "like slightly", "dislike slightly", "dislike moderately", "dislike very much", "dislike extremely" and "most disliked sensation imaginable". Responses will be coded on a 0-100 scale.
Puff Topography: puff duration
Puff duration is the measurement of the length of participant puffs in seconds during a 10-puff directed puffing bout (lasting 5-minutes) and during the 60-minute ad libitum bout where participants are instructed to puff as much or as little as they like on the ECIG.
Puff Topography: puff volume
Puff volume is the measurement of the size of participant puffs in milliliters during a 10-puff directed puffing bout (lasting 5-minutes) and during the 60-minute ad libitum bout where participants are instructed to puff as much or as little as they like on the ECIG.
Puff Topography: puff velocity
Puff velocity is the measurement of the speed of participant puffs in milliliters per second during a 10-puff directed puffing bout (lasting 5-minutes) and during the 60-minute ad libitum bout where participants are instructed to puff as much or as little as they like on the ECIG.

Full Information

First Posted
April 2, 2018
Last Updated
May 7, 2019
Sponsor
Virginia Commonwealth University
search

1. Study Identification

Unique Protocol Identification Number
NCT03496116
Brief Title
The Influence of Electronic (ECIG) Heater Resistance on ECIG Acute Effects
Official Title
The Influence of Electronic Cigarette Heater Resistance on Nicotine Delivery, Heart Rate, Subjective Effects and Puff Topography
Study Type
Interventional

2. Study Status

Record Verification Date
May 2019
Overall Recruitment Status
Completed
Study Start Date
May 21, 2018 (Actual)
Primary Completion Date
December 17, 2018 (Actual)
Study Completion Date
December 17, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Virginia Commonwealth University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to measure the individual and combined influence of electronic cigarette (ECIG) heating element resistance and liquid nicotine concentration on ECIG acute effects. Thirty-two experienced ECIG users will complete four independent laboratory sessions that will differ by heater resistance (0.5 ohm or 1.5 ohm) and liquid nicotine concentration (3 or 8 mg/ml). Other factors such as voltage, liquid solvent ratio, and liquid flavor will be held constant. Plasma nicotine concentration, subjective effects, and puffing behavior will be recorded for each condition.
Detailed Description
Electronic cigarettes (ECIGs) are a popular and rapidly evolving class of products. ECIG users can manipulate several device features including liquid nicotine concentration (mg/ml) and heating element resistance (ohms). An emerging class of ECIG models includes "sub-Ohm" devices that employ low resistance heaters that are often used to achieve high device power. Some clinical laboratory data suggest that high power devices deliver nicotine to the user effectively, even when paired with a low liquid nicotine concentration. However, given that ECIG heater resistance and liquid nicotine concentration have not been manipulated in clinical laboratory studies, the influence of these factors on ECIG acute effects remain unclear. The purpose of this clinical laboratory study is to measure the influence of heater resistance and liquid nicotine concentration on ECIG acute effects. Participants will attend the lab for four experimental sessions where they use an ECIG. For each session, the participants will be randomly assigned (like the flip of a coin) to receive an ECIG with one of two different levels of heating coil resistance (which will determine overall device power) and one of two different liquid nicotine concentrations. The four sessions will begin at approximately the same time each day, will be separated by at least 48 hours, and will not occur more than two times per week. The primary hypotheses are that the low resistance heater paired with the 8 mg/ml liquid nicotine concentration, will result in greater nicotine delivery and subjective effect profiles, suggestive of higher abuse potential. Results from this study will further our understanding of the factors that influence the dependence potential of ECIGs and could inform future regulation of these devices.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nicotine Dependence

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
38 (Actual)

8. Arms, Groups, and Interventions

Arm Title
ECIG Session: 0.5 Ohms, 3 mg
Arm Type
Experimental
Arm Description
Heating coil resistance 0.5 Ohms Liquid nicotine concentration 3 mg
Arm Title
ECIG Session 0.5 Ohms, 8 mg
Arm Type
Experimental
Arm Description
Heating coil resistance 0.5 Ohms Liquid nicotine concentration 8 mg
Arm Title
ECIG Session 1.5 Ohms, 3 mg
Arm Type
Experimental
Arm Description
Heating coil resistance 1.5 Ohms Liquid nicotine concentration 3 mg
Arm Title
ECIG Session 1.5 Ohms, 8 mg
Arm Type
Experimental
Arm Description
Heating coil resistance 1.5 Ohms Liquid nicotine concentration 8 mg
Intervention Type
Other
Intervention Name(s)
ECIG Session
Intervention Description
Participants will complete four sessions using an e-cigarette, including a 10-puff product use bout followed by a 60-minute ad lib bout over an approximately 4-hour period. The study conditions for each session (i.e., heater resistance and nicotine combinations) will be Latin-square ordered.
Primary Outcome Measure Information:
Title
Cmax: Plasma nicotine concentration (ng/ml)
Time Frame
Six blood samples are collected at each of the 4 visits. During each session, blood samples are collected 90,100,160,185,205,225 minutes into the session which lasts approximately 4 hours.
Secondary Outcome Measure Information:
Title
Withdrawal suppression: Hughes-Hatsukami Withdrawal Scale
Description
Contains 11 items. Administered on a computerized visual analogue scale that consists of a phrase centered on a horizontal line with "not at all" on the left and "extremely" on the right.. Responses range from 0-100.
Time Frame
Collected six times at each of the 4 visits. During each session, questions are collected 90,100,160,185,205,225 minutes into the session which lasts approximately 4 hours.
Title
Withdrawal suppression: Direct effects of nicotine scale
Description
Contains 9-items. Administered on a computerized visual analogue scale that consists of a phrase centered on a horizontal line with "not at all" on the left and "extremely" on the right.. Responses range from 0-100.
Time Frame
Collected six times at each of the 4 visits. During each session, questions are collected 90,100,160,185,205,225 minutes into the session which lasts approximately 4 hours.
Title
Withdrawal suppression: Tiffany Drobes Questionnaire of Smoking Urges
Description
Contains 10 items. Participants will be asked to rate each phrase on a 7-point scale ranging from 0 (Strongly disagree) to 7 (Strongly agree). The items from this scale will form two factors: Factor 1 (intention to smoke) and Factor 2 (anticipation of relief from abstinence symptoms).
Time Frame
Collected six times at each of the 4 visits. During each session, questions are collected 90,100,160,185,205,225 minutes into the session which lasts approximately 4 hours.
Title
Withdrawal suppression: Direct effects of ECIG use scale
Description
Contains 14-items. Administered on a computerized visual analogue scale that consists of a phrase centered on a horizontal line with "not at all" on the left and "extremely" on the right. Responses range from 0-100.
Time Frame
Collected six times at each of the 4 visits. During each session, questions are collected 90,100,160,185,205,225 minutes into the session which lasts approximately 4 hours.
Title
Other subjective effects: General Labeled Magnitude Scale
Description
Contains 4-items. This category-ratio scale contains seven semantic labels that increase in sensitivity including: "no sensation", "barely detectable", "weak", "moderate", "strong", "very strong", and "strongest imaginable sensation of any kind." Responses will be coded on a 0-100 scale.
Time Frame
Collected six times at each of the 4 visits. During each session, questions are collected 90,100,160,185,205,225 minutes into the session which lasts approximately 4 hours.
Title
Other subjective effects: Labeled Hedonic Scale
Description
Contains 4-items. This category-ratio scale contains ten semantic labels, intended to assess participant liking or disliking of sensations experienced in the general labeled magnitude scale.. Semantic labels include: "most liked sensation imaginable", "like extremely", "like very much", "like moderately", "like slightly", "dislike slightly", "dislike moderately", "dislike very much", "dislike extremely" and "most disliked sensation imaginable". Responses will be coded on a 0-100 scale.
Time Frame
Collected six times at each of the 4 visits. During each session, questions are collected 90,100,160,185,205,225 minutes into the session which lasts approximately 4 hours.
Title
Puff Topography: puff duration
Description
Puff duration is the measurement of the length of participant puffs in seconds during a 10-puff directed puffing bout (lasting 5-minutes) and during the 60-minute ad libitum bout where participants are instructed to puff as much or as little as they like on the ECIG.
Time Frame
Collected twice at each of the 4 visits. During each session, puff duration is measured at 95 and 225 minutes.
Title
Puff Topography: puff volume
Description
Puff volume is the measurement of the size of participant puffs in milliliters during a 10-puff directed puffing bout (lasting 5-minutes) and during the 60-minute ad libitum bout where participants are instructed to puff as much or as little as they like on the ECIG.
Time Frame
Collected twice at each of the 4 visits. During each session, puff duration is measured at 95 and 225 minutes.
Title
Puff Topography: puff velocity
Description
Puff velocity is the measurement of the speed of participant puffs in milliliters per second during a 10-puff directed puffing bout (lasting 5-minutes) and during the 60-minute ad libitum bout where participants are instructed to puff as much or as little as they like on the ECIG.
Time Frame
Collected twice at each of the 4 visits. During each session, puff duration is measured at 95 and 225 minutes.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Willing to provide informed consent, attend the lab and abstain from nicotine/tobacco as required, and use designated products according to study protocol Experienced ECIG users (use ≥1 ml of ECIG solution daily, use ECIG solution with a nicotine concentration ≥3 mg/ml, and have used their ECIG for ≥3 months) Urine cotinine test result ≥ 3 Exclusion Criteria: History of organ-related diseases or current psychiatric condition Regular use of prescription medication other than vitamins or birth control Past month use of cocaine, opioids, benzodiazepines, or methamphetamine Using marijuana greater than 10 days in the past 30 and/or alcohol greater than 25 days in the past 30 days Pregnant or breastfeeding women Weight less than 110 pounds Daily use of >5 cigarettes or use of other tobacco products (i.e., hookah, cigars) >3 times a week
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas E Eissenberg, PhD
Organizational Affiliation
Virginia Commonwealth University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Virginia Commonwealth University
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23298
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

The Influence of Electronic (ECIG) Heater Resistance on ECIG Acute Effects

We'll reach out to this number within 24 hrs